Details for 2012000665

Up to date per 04.04.2026

Actions

Title / Product Name

Verwendung von zellpermeablen Peptid-Inhibitoren des JNK-Signal-Transduktionspfads zur Behandlung verschiedener kardiovaskulären Erkrankungen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012000665

EP Publication Number

2491942

E-Number

637182

Language

PCT Number

Publication Date

29.08.2012 A

23.10.2013 B1

Registration Date

23.10.2013

AT Publication Date

15.11.2013

Application Date

02.06.2009

Registration Number

Priorities

30.05.2008

PCT/EP2008/004341

IPC

A61K 38/28 20060101AFI20121109BHEP

Maximum Duration of Protection

02.06.2029

Owner

Xigen Inflammation Ltd.Arch. Makariou III 195 Neocleous House 3030 LimassolCY

Representative

Torggler P.Mag.Dr., Hofinger St.Dipl.Ing.Dr., Gangl M. Mag.Dr., Maschler Chr.MMag.Dr. INNSBRUCK ( T)

Inventor

Bonny, Christophe37c, chemin du Trabandan 1006 LausanneCH